Drug Shortage Report for VINORELBINE INJECTION, USP

Last updated on 2019-10-11 History
Report ID 89588
Drug Identification Number 02431130
Brand name VINORELBINE INJECTION, USP
Common or Proper name Vinorelbine for Injection
Company Name GENERIC MEDICAL PARTNERS INC
Market Status MARKETED
Active Ingredient(s) VINORELBINE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5 ml Vial. Each pack contains one vial.
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-07-01
Actual start date 2019-07-01
Estimated end date 2019-10-01
Actual end date 2019-10-10
Shortage status Resolved
Updated date 2019-10-11
Company comments Shortage over. GMP has removed, with effect 10 October, the 75% allocation on Vinorelbine 10 mg/ml 5 ml vials for all contracted accounts and direct off contract orders.
Health Canada comments
Tier 3 Status No
Contact Address 1500 DON MILLS ROAD, SUITE 711
TORONTO, ONTARIO
CANADA M3B 3K4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-07-18 English Compare
v2 2019-07-18 English Compare
v3 2019-07-18 English Compare
v4 2019-07-18 English Compare
v5 2019-07-18 French Compare
v6 2019-09-10 English Compare
v7 2019-09-10 English Compare
v8 2019-09-10 English Compare
v9 2019-09-10 French Compare
v10 2019-10-10 English Compare
v11 2019-10-10 English Compare
v12 2019-10-10 English Compare
v13 2019-10-10 French Compare
v14 2019-10-11 English Compare

Showing 1 to 14 of 14